The Recall Desk
HighFDA (Drugs)·D-0398-2025·Announced 2025-05-07

[pending] NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)

Pending LLM rewrite. Source: FDA_DRUG D-0398-2025.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

The recalled product

Product
NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)
Brand
NICARDIPINE HYDROCHLORIDE
Manufacturer
American Regent, Inc.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (15)

  • Lots
  • expiry: Lot 24025N0C0
  • 6/30/2025
  • Lot 24115N0C0
  • 10/31/2025
  • Lot 24116N0C0
  • 3/31/2026
  • Lot 24160N0C0
  • 12/31/2025
  • Lot 24217N0C0
  • 01/31/2026
  • Lot 24288N0C0
  • 04/30/2026
  • Lot 24331N0C0
  • 5/31/2026

Distribution

Distributed nationwide across the United States.